SCHEMBL7984468

SCHEMBL7984468

CCc1nc(O)c2c(ncn2Cc2ccc(C(C)(C)C)cc2)n1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABCC8 Q09428 1/20 0.46
KCNJ11 Q14654 1/20 0.46
NR1H4 Q96RI1 6/20 0.40
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
HSP90AA1 P07900 2/20 0.35
HSP90AB1 P08238 2/20 0.35
NR1I2 O75469 1/20 0.34
EGLN3 Q9H6Z9 1/20 0.34
CCR9 P51686 2/20 0.33
MET P08581 2/20 0.33
HPGD P15428 1/20 0.33
F2R P25116 1/20 0.33
EPHX2 P34913 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984746 0.92 ABCC8 (0.46) ABCC8KCNJ11NR1H4CYP11B1CYP11B2
SCHEMBL7988129 0.87 MET (0.44) ABCC8KCNJ11METHPGDALDH1A1
SCHEMBL7991685 0.87 ABCC8 (0.44) ABCC8KCNJ11NR1H4CYP11B1CYP11B2
SCHEMBL7985639 0.87 ABCC8 (0.44) ABCC8KCNJ11NR1H4CYP11B1CYP11B2
Hydrochloric Acid SCHEMBL7985465 0.86 ABCC8 (0.43) ABCC8KCNJ11NR1H4CYP11B1CYP11B2
SCHEMBL7987434 0.86 CYP11B1 (0.42) CYP11B1CYP11B2METHPGDALDH1A1
SCHEMBL7984526 0.85 MET (0.46) CYP11B1CYP11B2METHPGDALDH1A1
SCHEMBL7975252 0.85 HPGD (0.45) CYP11B1CYP11B2HPGDALDH1A1SMN1; SMN2
SCHEMBL8059823 0.83 MEN1 (0.45) NR1H4HPGDALDH1A1SMN1; SMN2
SCHEMBL7973934 0.83 CYP11B1 (0.45) CYP11B1CYP11B2METHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed